Certified by Founder Lodge
Long River Investment Management Limited
Hong Kong - Hong Kong
INVESTOR
1 Disclosed Funding Rounds $50,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are an investment management company that focuses on Value Investing on publicly listed companies in U.S., Hong Kong and mainland China.
| Company | Date | Round | Raised |
|---|---|---|---|
 Allorion Therapeutics |
March, 13 ,2023 | Series B | $50,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
